Sun Pharma gets USFDA import ban on Gujarat plant

The United States Food and Drug Administration (USFDA) has imposed an import alert, effectively a ban, on generic drugmaker Sun Pharmaceutical Industries Ltd's plant in Gujarat.

An "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices, according to the FDA website.

A spokesman for Sun, India's biggest drugmaker by market value, was not available for comment.

The plant in Karkhadi in Gujarat makes both drug ingredients and formulations, according to Sun's 2013 annual report.


  • Centre and states must cooperate to get the economy moving

    Mirroring the previous three quarters, another round of tepid corporate earnings announcements are expected in a few days from now.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Arun Nigavekar

Ranking of higher education institutions

Given the massive popularity and growing influence of world university ...

Rajgopal Nidamboor

The pursuit of serene stillness

It may sound strange — that every change in the ...

Dharmendra Khandal

How positive intervention can go a long way

Ten years ago, Sariska tiger reserve declared that there were ...


William D. Green

Chairman & CEO, Accenture